Biotron Limited
BITRF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Market Cap | $16 | $16 | $49 | $88 |
| - Cash | $1 | $1 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $15 | $15 | $49 | $88 |
| Revenue | -$0 | $2 | $0 | $2 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | -$0 | $2 | -$0 | $2 |
| % Margin | 100% | 100% | – | 100% |
| EBITDA | -$1 | $1 | -$2 | -$1 |
| % Margin | 118,854.1% | 38.8% | – | -82.1% |
| Net Income | -$1 | $1 | -$2 | -$1 |
| % Margin | 116,958.5% | 38.4% | – | -80.5% |
| EPS Diluted | -0.001 | 0.001 | -0.002 | -0.001 |
| % Growth | -266.7% | 125% | -71.4% | – |
| Operating Cash Flow | -$1 | $0 | -$0 | -$3 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$1 | $0 | -$0 | -$3 |